Product NDC: | 0135-0461 |
Proprietary Name: | ALLI |
Non Proprietary Name: | orlistat |
Active Ingredient(s): | 60 mg/1 & nbsp; orlistat |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0135-0461 |
Labeler Name: | GlaxoSmithKline Consumer Healthcare LP |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | NDA021887 |
Marketing Category: | NDA |
Start Marketing Date: | 20070207 |
Package NDC: | 0135-0461-07 |
Package Description: | 21 CAPSULE in 1 BOTTLE (0135-0461-07) |
NDC Code | 0135-0461-07 |
Proprietary Name | ALLI |
Package Description | 21 CAPSULE in 1 BOTTLE (0135-0461-07) |
Product NDC | 0135-0461 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | orlistat |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20070207 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline Consumer Healthcare LP |
Substance Name | ORLISTAT |
Strength Number | 60 |
Strength Unit | mg/1 |
Pharmaceutical Classes |